Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Tolerability of the Oral Targeted Anticancer Drug Pazopanib by Food Intake (DIET)

NCT02138526 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02138526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02138526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Tolerability of the Oral Targeted Anticancer Drug Pazopanib by Food Intake (DIET)
Lead sponsor
Radboud University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2014
Completion date
November 30, 2018
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer